Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RAB Special Situations (Master) Fund is a prominent hedge fund managed by RAB Capital, specializing in 'special situations' investments across the natural resources and life sciences sectors. The fund was particularly active on the London Stock Exchange's Alternative Investment Market (AIM), where it acted as a cornerstone investor for numerous emerging biotechnology and mining companies. At its height, it was recognized for its aggressive, high-conviction investment strategy led by founder Philip Richards. However, following the 2008 global financial crisis, the fund experienced significant losses and liquidity issues, leading to its eventual restructuring and the delisting of its management company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RAB Special Situations (Master) Fund.